Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Response Biomedical Signs Second China Partner

publication date: Feb 2, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Response Biomedical Corporation signed up a second partner to market its diagnostic products in China. Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) in China will sell Response Biomedical’s cardiac offerings as private label products. O&D Biotech Co. will continue to market the same diagnostic tests as co-branded RAMP® products on both the RAMP® and RAMP® 200 Readers. More details...

Stock Symbol: (TSX: RBM, OTCBB: RPBIF)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...